Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
53°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
766.68
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
77
78
Next >
$3,000 Invested in These 3 Top Stocks Could Make You Rich in 10 Years
November 23, 2023
Plug into a trio of megatrends with these three particular tickers.
Via
The Motley Fool
Will Eli Lilly Be Worth More Than Tesla by 2027?
November 23, 2023
It's a lot more likely than it sounds.
Via
The Motley Fool
3 Healthcare Stocks to Scoop Up as They Change the Medical Landscape
November 22, 2023
Consider one of these three leading-edge healthcare stocks from companies focused on significant medical innovations.
Via
InvestorPlace
$1000 Invested In Eli Lilly 10 Years Ago Would Be Worth This Much Today
November 22, 2023
Via
Benzinga
Eli Lilly and Novo Nordisk Are Big Names in Weight Loss, but Investors Shouldn't Count Out This Healthcare Giant
November 22, 2023
Could AstraZeneca be an under-rated buy right now?
Via
The Motley Fool
The Best Stocks to Invest $5,000 in Right Now
November 22, 2023
Here's how to safeguard your money and grow richer.
Via
The Motley Fool
Uncovering Noteworthy Technical Analysis Findings for ELI LILLY & CO (NYSE:LLY).
November 21, 2023
Promising Signs: ELI LILLY & CO Setting the Stage for a Breakout.
Via
Chartmill
Analyst Expectations for Eli Lilly's Future
November 20, 2023
Via
Benzinga
A Look Into Eli Lilly Inc's Price Over Earnings
November 20, 2023
Via
Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
Recent advancements in Alzheimer's disease treatments targeting the removal of toxic proteins (white matter) from the brain have sparked a renewed interest in developing vaccines to combat this
Via
Benzinga
Magnificent 7 Take Center Stage In Hedge Fund Portfolios: Analysts Warn Of Extreme Concentration
November 21, 2023
Hedge fund portfolios are intensifying their focus on technology stocks, with holdings in mega-cap tech reaching record levels.
Via
Benzinga
Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF?
November 21, 2023
New class of weight-reducing drugs underpin launch of exchange-traded fundTema launches healthcare ETF focused on companies researching and treating cardiovascular disease, obesity and diabetes,...
Via
Benzinga
Topics
ETFs
Eli Lilly Options Trading: A Deep Dive into Market Sentiment
November 17, 2023
Via
Benzinga
Better Growth Stock: Novo Nordisk vs. Eli Lilly
November 16, 2023
These companies have been attracting plenty of attention lately.
Via
The Motley Fool
Ignore Eli Lilly. These 2 Stocks Are Better Buys Right Now
November 21, 2023
Investors have favored an exciting billion-dollar opportunity at Eli Lilly.
Via
The Motley Fool
Eli Lilly Just Got One Step Closer to Dethroning Ozempic. Time to Buy the Stock?
November 19, 2023
Eli Lilly just received FDA approval for its obesity medication Zepbound, the sister treatment to its blockbuster drug Mounjaro.
Via
The Motley Fool
Exposures
Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
November 17, 2023
Via
Benzinga
The Relative Strength Index (RSI) Indicator: Does It Work?
November 17, 2023
The Relative Strength Index (RSI) is a contrarian technical analysis indicator that uses prices to find "overbought" and "oversold" assets.
Via
InvestorPlace
Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning
November 17, 2023
Biotech companies are edging closer to finding the answers behind Alzheimer's disease.
Via
Investor's Business Daily
Goldman Sachs' 2024 Equity Outlook: Winning Stocks And Sectors To Watch
November 16, 2023
Dive into Goldman Sachs' 2024 Equity Outlook, detailing a positive forecast for the S&P 500, sector-specific strategies, and key stock picks for navigating a year of growth and stability.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Pharmaceutical Giant Eli Lilly Plans Expansion In Germany, Eyes Diabetes Drug Production: Report
November 16, 2023
Eli Lilly And Co (NYSE: LLY) reportedly intends to construct a production plant in western Germany with an estimated investment of €2 billion ($2.17 billion), marking an inaugural substantial...
Via
Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
November 16, 2023
Via
Benzinga
If You Invested $10,000 in Eli Lilly in 2013, This Is How Much You Would Have Today
November 16, 2023
Is it too late to invest in Eli Lilly's stock?
Via
The Motley Fool
Why Eli Lilly Stock Flopped While the Market Popped Today
November 15, 2023
The company is apparently gearing up to spend at least $1 billion on a production facility in Europe.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 15, 2023
Via
Benzinga
Ozempic Shortage Crisis - Germany Weighs Export Restrictions on Novo Nordisk's Drug
November 15, 2023
Germany's Federal Institute for Drugs and Medical Devices (BfArM) is reportedly contemplating a potential export prohibition on Novo Nordisk A/S's (NYSE: NVO) popular diabetes medication, Ozempic,
Via
Benzinga
Why It’s Time to Sell These 3 Hot Stocks
November 14, 2023
Holding onto a stock too long can lead to an evaporation of profits. Better for investors to sell a little too early than a little too late.
Via
InvestorPlace
Eli Lilly Is Planning to Dominate the Weight Loss Market and Make Billions. Here's Why It'll Keep Winning
November 14, 2023
It's already taking actions to shore up its future position.
Via
The Motley Fool
Royal Rule: Buy These 3 Dividend Aristocrats on Every. Single. Dip.
November 13, 2023
Choosing dividend aristocrats to buy becomes easy when you elect to buy the royalty of income-generating stocks.
Via
InvestorPlace
What Are Pfizer's Prospects In Obesity Pill Market? Analysts Say Optimism, Cautiousness Surround With Data Awaited Next Year
November 13, 2023
Pfizer Inc (NYSE: PFE) is turning its focus to the weight loss drug market, aiming to capture a $10 billion segment with its experimental obesity
Via
Benzinga
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
77
78
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.